Tag Archives: NYSE:TMO

Barclays Maintains a Buy Rating on Thermo Fisher (TMO)

Barclays analyst Jack Meehan maintained a Buy rating on Thermo Fisher (TMO – Research Report) today and set a price target of $280. The company’s shares opened today at $218.76. According to TipRanks.com, Meehan is a 4-star analyst with an

Thermo Fisher (NYSE: TMO) Executives are Making Moves with Their Shares

Today, a Director at Thermo Fisher (TMO – Research Report), Tyler Jacks, sold shares of TMO for $277.2K. Following Tyler Jacks’ last TMO Sell transaction on November 20, 2018, the stock climbed by 18.6%. In addition to Tyler Jacks, one

Morgan Stanley Believes Thermo Fisher (NYSE: TMO) Won’t Stop Here

Morgan Stanley analyst Steve Beuchaw maintained a Buy rating on Thermo Fisher (NYSE: TMO) today and set a price target of $216. The company’s shares closed yesterday at $215.19, close to its 52-week high of $226.44. Beuchaw has an average

Morgan Stanley Believes Thermo Fisher (NYSE: TMO) Still Has Room to Grow

In a report released today, Steve Beuchaw from Morgan Stanley maintained a Buy rating on Thermo Fisher (NYSE: TMO), with a price target of $227. The company’s shares opened today at $224.16, close to its 52-week high of $226.44. According

Analysts’ Top Healthcare Picks: TMO, SPPI

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Thermo Fisher (NYSE: TMO) and Spectrum Pharmaceuticals (NASDAQ: SPPI) with bullish sentiments. Thermo Fisher (NYSE: TMO) In a report released today, Puneet

Thermo Fisher Receives a Rating Update from a Top Analyst

Jefferies analyst Brandon Couillard reiterated a Hold rating on Thermo Fisher (NYSE: TMO) yesterday and set a price target of $195. The company’s shares closed yesterday at $188.47, close to its 52-week high of $194.30. According to TipRanks.com, Couillard is